Johnson & Johnson (JNJ)

JNJ (NYSE:Drugs)
$106.77
pos +0.23
+0.21%
Today's Range: 106.45 - 107.21 | JNJ Avg Daily Volume: 6,240,400
Last Update: 09/30/14 - 3:56 PM EDT
Volume: 4,866,501
YTD Performance: 16.32%
Open: $106.50
Previous Close: $106.54
52 Week Range: $85.50 - $108.77
Oustanding Shares: 2,820,287,326
Market Cap: 302,052,772,615
6-Month Chart
TheStreet Ratings Grade for JNJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 5 4 4 4
Moderate Buy 3 3 3 3
Hold 8 8 8 8
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.19 2.27 2.27 2.27
Latest Dividend: 0.70
Latest Dividend Yield: 2.61%
Dividend Ex-Date: 08/22/14
Price Earnings Ratio: 19.80
Price Earnings Comparisons:
JNJ Sector Avg. S&P 500
19.80 19.80 28.46
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.48% 22.84% 66.73%
GROWTH 12 Mo 3 Yr CAGR
Revenue 6.10 0.16 0.05
Net Income 31.50 0.04 0.01
EPS 24.60 0.01 0.00
Earnings for JNJ:
EBITDA 23.06B
Revenue 71.31B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.42 $1.29 $5.92 $6.34
Number of Analysts 9 8 14 13
High Estimate $1.49 $1.35 $6.01 $6.48
Low Estimate $1.34 $1.22 $5.87 $6.24
Prior Year $1.36 $1.24 $5.52 $5.92
Growth Rate (Year over Year) 4.58% 4.23% 7.30% 7.08%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Dick Arms

 | Sep 30, 2014 | 7:00 AM EDT

Overbought levels suggest decline is headed lower.

bullishJohnson & Johnson rated new Outperform at BMO

Sep 5, 2014 | 8:12 AM EDT

JNJ was initiated with an Outperform rating, BMO Capital said. $118 price target. Company is a market leader and can expand into emerging markets.

By

Jim Cramer

 | Aug 11, 2014 | 11:49 AM EDT

Like others, it's perennially cautious. And you can profit from that.

By

Timothy Collins

 | Aug 8, 2014 | 3:57 PM EDT
Here is my technical analysis of the Action Alerts PLUS portfolio positions: 'The At-Risk.'
By

Jim Cramer

 | Jul 22, 2014 | 10:52 AM EDT

These moves are all just random to that day, and nothing else.

By

Doug Kass

 | Jul 15, 2014 | 7:49 AM EDT
Where it began.

bearishJohnson & Johnson price target, estimates raised at Jefferies

Jul 14, 2014 | 8:13 AM EDT

JNJ upped its numbers, Jefferies said. Reflecting strong performance from Olysio. $114 price target and Hold rating. 

By

Doug Kass

 | Jul 14, 2014 | 8:06 AM EDT
Where it began.
By

Jim Cramer

 | Jul 3, 2014 | 11:10 AM EDT

I focus on the unemotional probabilities, as they win more often than not.

By

Sham Gad

 | Jun 25, 2014 | 2:00 PM EDT

Let's hear how the pros would finish that sentence.

We are still seeing WYNN hold up above key WEEKLY support here, but I do want to show you ...
Market moving down in last hour as dollar continues to strengthen against major currencies...
The daily chart of Regeneron Phamaceuticals (REGN) shows Bollinger bandwidth contraction ...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.